
Chinese pharmaceutical research company established on 22 August 2017 in the China (Shanghai) Pilot Free Trade Zone at Faraday Road and Libing Road in Zhangjiang, with Zhu Yidong as legal representative. Serves as the Shanghai innovative drug research centre of the Qilu Pharmaceutical group, acting as its combined platform for innovative drug research, talent development and international collaboration and taking charge of overall planning and project development for the group's small molecule and large molecule innovative drugs. Its scope covers drug research and development together with technology development, consulting, services and transfer in biotechnology and pharmaceutical science, business consulting and goods and technology import and export, supporting the group's work on oncology, cardio-cerebrovascular, anti-infective, psychiatric, neurological and ophthalmic medicines and their active ingredients.
Ver perfil de la empresa
Deja tu valoración